Suppression of CYP2C9 expression has been reported as a biomarker of HCC14, 15, 16, 17; however, the mechanism of CYP2C9 dysregulation through microRNA (miRNAs) modulation has not been investigated in HCC. Here, CYP2C9 is linked to hepatocellular carcinoma.